RPA-CRISPR/Cas12a detection based on HCMV-UL123 gene: A way with higher detection rate than clinical detection methods
Journal of Infection and Public Health · 2025
DOI: 10.1016/j.jiph.2025.102845 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Tianyang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China; National Clinical Research Center for In…. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections, CRISPR-Cas Systems, Molecular Diagnostic Techniques. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
OBJECTIVE: Human cytomegalovirus (HCMV), a prevalent double-stranded DNA enveloped virus, poses a threat to immunocompromised individuals. The current clinical detection methods are insufficient in sensitivity, highlighting the need for more effective approaches. METHODS: We designed and screened RPA primers and crRNA based on the UL123 gene of HCMV. Evaluate the HCMV-RPA-CRISPR detection method using cloned plasmids and the whole-genome samples of HCMV-infected cells. Conduct RPA-CRISPR/Cas12a reactions with 48 clinical samples and compare the results with those of PCR-Fluorescent Probe Method in clinical applications and the qPCR method for detecting the UL123 gene. RESULTS: The optimized RPA-CRISPR system exhibited high sensitivity and specificity for HCMV detection. The positive rate of clinical sample detection was approximately 20.5 % (6/48) higher than that of the clinical detection method. CONCLUSION: Currently, the sensitivity and early detection of HCMV in clinical settings are still limited. The UL123 gene of HCMV is characterized by high transcription in the early stage and high conservation. The RPA-CRISPR/Cas12a technology exhibits high sensitivity in detecting the HCMV UL123 gene, and it is expected to provide a more effective method for the early specific detection of HCMV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China; National Clinical Research Center for Infectious Diseases, Institute for Hepatology, Shenzhen Third People's H…
- The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China; Department of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
- Department of Neurosurgery, The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Liu, T., Wang, Y., Liao, Z., Li, X., Tang, S., Zhang, Z., Chu, M., & Wei, L. (2025). RPA-CRISPR/Cas12a detection based on HCMV-UL123 gene: A way with higher detection rate than clinical detection methods. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102845
Vancouver
Liu T, Wang Y, Liao Z, Li X, Tang S, Zhang Z, et al. RPA-CRISPR/Cas12a detection based on HCMV-UL123 gene: A way with higher detection rate than clinical detection methods. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102845
BibTeX
@article{Liu2025,
author = {Liu, Tianyang and Wang, Yao and Liao, Zihao and Li, Xiaowen and Tang, Shanshan and Zhang, Zhongming and Chu, Ming and Wei, Lanlan},
title = {RPA-CRISPR/Cas12a detection based on HCMV-UL123 gene: A way with higher detection rate than clinical detection methods},
journal = {Journal of Infection and Public Health},
year = {2025},
doi = {10.1016/j.jiph.2025.102845}
}
EUVIMED